Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Summary

RATIONALE: Voriconazole may be effective in preventing systemic fungal infections following chemotherapy. PURPOSE: Phase II trial to study the effectiveness of voriconazole in preventing systemic fungal infections in children who have neutropenia after receiving chemotherapy for leukemia, lymphoma, or aplastic anemia or in preparation for bone marrow or stem cell transplantation.

Timeline

Start

2003-06

Primary completion

—

Completion

2004-06

Drugs

Indications